Cherng, H.-J. J., & Herrera, A. (2024). Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside? Current Treatment Options in Oncology, 25(5), 659–678. https://doi.org/10.1007/s11864-024-01201-8

Cuzzo, B., Lipsky, A., & Cherng, H.-J. J. (2023). Measurable Residual Disease Monitoring in Lymphoma. Current Hematologic Malignancy Reports, 18(6), 292–304. https://doi.org/10.1007/s11899-023-00715-6

Raufi, A. G., May, M. S., Hadfield, M. J., Seyhan, A. A., & El-Deiry, W. S. (2023). Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer. International Journal of Molecular Sciences, 24(4), 4238. https://doi.org/10.3390/ijms24044238

Hou, J. Y., Chapman, J. S., Kalashnikova, E., Pierson, W., Smith-McCune, K., Pineda, G., Vattakalam, R. M., Ross, A., Mills, M., Suarez, C. J., Davis, T., Edwards, R., Boisen, M., Sawyer, S., Wu, H.-T., Dashner, S., Aushev, V. N., George, G. V., Malhotra, M., … Ford, J. M. (2022). Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer. Gynecologic Oncology, 167(2), 334–341. https://doi.org/10.1016/j.ygyno.2022.09.004